Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Vertex Pharmaceuticals Incorporated (VRTX) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$12.00B |
|
$3.95B |
|
$1.65B |
|
$10.35B |
|
$7.83B |
|
$4.17B |
|
$469.90M |
|
$4.64B |
|
$4.64B |
|
$3.95B |
|
$3.95B |
|
$3.95B |
|
$3.95B |
|
$4.17B |
|
$4.38B |
|
255.70M |
|
258.00M |
|
$15.46 |
|
$15.32 |
|
| Balance Sheet Financials | |
$11.20B |
|
$1.52B |
|
$14.44B |
|
$25.64B |
|
$3.86B |
|
-- |
|
$3.12B |
|
$6.98B |
|
$18.67B |
|
$17.15B |
|
$18.67B |
|
253.99M |
|
| Cash Flow Statement Financials | |
$3.63B |
|
$-945.40M |
|
$-2.26B |
|
$4.57B |
|
$5.09B |
|
$515.60M |
|
$685.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.90 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
-- |
|
-- |
|
86.24% |
|
34.77% |
|
34.77% |
|
36.52% |
|
38.69% |
|
32.94% |
|
$3.19B |
|
-- |
|
-- |
|
-- |
|
0.47 |
|
0.98 |
|
5.85 |
|
62.43 |
|
21.18% |
|
23.05% |
|
15.42% |
|
21.18% |
|
$73.49 |
|
$12.38 |
|
$14.08 |
|